GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Yatai Pharmaceutical Co Ltd (SZSE:002370) » Definitions » Financial Strength

Zhejiang Yatai Pharmaceutical Co (SZSE:002370) Financial Strength : 3 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zhejiang Yatai Pharmaceutical Co Financial Strength?

Zhejiang Yatai Pharmaceutical Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.

Warning Sign:

Zhejiang Yatai Pharmaceutical Co Ltd displays poor financial strength. Usually, this is caused by too much debt for the company.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Zhejiang Yatai Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 0.43. Zhejiang Yatai Pharmaceutical Co's debt to revenue ratio for the quarter that ended in Mar. 2024 was 1.41. As of today, Zhejiang Yatai Pharmaceutical Co's Altman Z-Score is 0.62.


Competitive Comparison of Zhejiang Yatai Pharmaceutical Co's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Yatai Pharmaceutical Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Yatai Pharmaceutical Co's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Yatai Pharmaceutical Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Zhejiang Yatai Pharmaceutical Co's Financial Strength falls into.



Zhejiang Yatai Pharmaceutical Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Zhejiang Yatai Pharmaceutical Co's Interest Expense for the months ended in Mar. 2024 was ¥-8.9 Mil. Its Operating Income for the months ended in Mar. 2024 was ¥3.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥636.5 Mil.

Zhejiang Yatai Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is

Interest Coverage=-1*Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*3.86/-8.929
=0.43

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Zhejiang Yatai Pharmaceutical Co's Debt to Revenue Ratio for the quarter that ended in Mar. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 636.53) / 450.852
=1.41

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Zhejiang Yatai Pharmaceutical Co has a Z-score of 0.62, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of 0.62 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Yatai Pharmaceutical Co  (SZSE:002370) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Zhejiang Yatai Pharmaceutical Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.


Zhejiang Yatai Pharmaceutical Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Zhejiang Yatai Pharmaceutical Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Yatai Pharmaceutical Co (SZSE:002370) Business Description

Traded in Other Exchanges
N/A
Address
No. 1152, Yunji Road, Keqiao District, Zhejiang province, Shaoxing, CHN, 312030
Zhejiang Yatai Pharmaceutical Co Ltd is a China-based company engaged in the research, production, and sales of pharmaceutical drugs. Its product portfolio includes tablets, hard capsules, transdermal patches, freeze-dried powder injections, powder injections, azithromycin, roxithromycin and other products. The company sells its products both in China and other international countries.
Executives
Wang Li Yun Executives
Zhong Wan Zhen Director
Lv Xu Xing Director
Shen Yi Yi Directors, Directors, and Executives
He Zhen Directors, executives
Zhu Feng Securities Affairs Representative
Ren Jun Director
Ping Hua Biao Director
Chen Yao Gen Directors, executives

Zhejiang Yatai Pharmaceutical Co (SZSE:002370) Headlines

No Headlines